SentreHEART, Inc., the manufacturer of the LARIAT technology for catheter-based, non-implant left atrial appendage closure (LAAC), announced it has closed a $35 million Series D round of financing. Deerfield Management Company, a healthcare...
SentreHEART, Inc., the manufacturer of the LARIAT technology for catheter-based, non-implant left atrial appendage closure (LAAC), announced it has closed a $35 million Series D round of financing. Deerfield Management Company, a healthcare...
SentreHEART, Inc., the...